A Medical Device Daily

GenVault (San Diego), which bills itself as an integrated biosample management company, reported that it will acquire full rights to the DNA labeling intellectual property invented by Nigel Atkinson and Brian Haarer, researchers at the University of Texas (Austin).

GenVault said that the patent allows GenVault to offer GenCode, its DNA labeling technology, to a broader market and positions it as the only company to offer double labeling for nucleic acid samples. GenCode said it offers the benefit of a barcode that permanently identifies each biosample and remains with the sample even after removal from its container and eluted from its original storage medium. Therefore, a sample can be traced back to the original sample, regardless of its physical state.

David Wellis, senior vice president, marketing and sales for GenVault, said, “DNA labeling has been an integral part of our system that improves upon current biosample labeling techniques.”